Regulation of mitofusin-2 expression in skeletal muscleThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.
- 1 June 2009
- journal article
- review article
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 34 (3) , 433-439
Abstract
Fusion and fission of mitochondria regulate their morphology and distribution. Mitofusin-2 (Mfn2) is a mitochondrial protein involved in such fusion. Recent observations indicate that Mfn2 is a multifunctional protein that participates in cell proliferation and metabolism and that it is required for normal endoplasmic reticulum morphology. In relation to the metabolic role of Mfn2, alterations in activity have been reported to modify cell respiration, substrate oxidation, and oxidative phosphorylation subunit expression in cultured nonmuscle and muscle cells. Mfn2 expression in skeletal muscle is subject to regulation and conditions characterized by reduced mitochondrial activity, such as obesity or type 2 diabetes, and are associated with repressed Mfn2 . In contrast, cold-exposure treatment with β3-adrenergic agonists or exercise induce the expression of this gene in muscle. Estrogen-related receptor-α transcription factor is a key regulator of Mfn2 transcription and recruits peroxisome proliferator-activated receptor γ coactivator (PGC)-1β and PGC-1α. These 2 nuclear coactivators are potent, positive regulators of Mfn2 expression in muscle cells, and ablation of PGC-1β causes Mfn2 downregulation in skeletal muscle and in the heart. We propose that PGC-1β is a regulator of normal expression of Mfn2 in muscle, whereas PGC-1α participates in the stimulation of Mfn2 expression under a variety of conditions characterized by enhanced energy expenditure.Keywords
This publication has 51 references indexed in Scilit:
- Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1βPLOS ONE, 2008
- OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1LJournal of Cell Biology, 2007
- Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell deathJournal of Cell Biology, 2007
- PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosisProceedings of the National Academy of Sciences, 2007
- Ablation of PGC-1β Results in Defective Mitochondrial Activity, Thermogenesis, Hepatic Function, and Cardiac PerformancePLOS Biology, 2006
- Regulation of mitochondrial morphology through proteolytic cleavage of OPA1The EMBO Journal, 2006
- PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic SteatosisPLOS Biology, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA.Molecular Biology of the Cell, 1997
- Recombination of mitochondrial drug-resistance factors in Saccharomyces, cerevisiaeBiochemical and Biophysical Research Communications, 1968